SPONSOR

Insel Gruppe AG, University Hospital Bern

Total Trials

Recruiting

Phases

Phase 2

Conditions studied: Kidney Stone Maturation of the Healthy Infant Intestinal Microbiota Microbial Colonization Nutrition Disorder, Infant Milk Expression, Breast Mental Health Disorder Thrombus of Left Ventricle Endocarditis Sepsis Septic Shock

Insel Gruppe AG, University Hospital Bern is a clinical research sponsor with 23 registered studies on ClinicalTrials.gov, of which 23 are actively recruiting participants. Research covers conditions including Kidney Stone, Maturation of the Healthy Infant Intestinal Microbiota, Microbial Colonization, Nutrition Disorder, Infant.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Insel Gruppe AG, University Hospital Bern

How many clinical trials has Insel Gruppe AG, University Hospital Bern sponsored?

ClinicalMetric currently tracks 23 clinical trials sponsored by Insel Gruppe AG, University Hospital Bern, of which 23 are actively recruiting participants. These trials cover conditions including Kidney Stone, Maturation of the Healthy Infant Intestinal Microbiota, Microbial Colonization. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Insel Gruppe AG, University Hospital Bern research focus on?

Insel Gruppe AG, University Hospital Bern clinical trials span Kidney Stone, Maturation of the Healthy Infant Intestinal Microbiota, Microbial Colonization, Nutrition Disorder, Infant, Milk Expression, Breast, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Insel Gruppe AG, University Hospital Bern clinical trial?

To participate in a Insel Gruppe AG, University Hospital Bern trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Insel Gruppe AG, University Hospital Bern trials with current recruitment status updated daily.

Insel Gruppe AG, University Hospital Bern

Frequently Asked Questions — Insel Gruppe AG, University Hospital Bern

Clinical Trials by Insel Gruppe AG, University Hospital Bern

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

Bern Birth Cohort / Trajectory of Microbiota Maturation in Healthy Bern Infants - a Network Approach

Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era

Cytokine REmoval in CRitically Ill PAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE)

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Multimodal Prehabilitation for Surgery in the Elderly: a Randomised, Prospective, Multicenter, Multidisciplinary Trial

Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions

Prophylactic Laparoscopic Suspension After McCall

Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions

The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer

Fremanezumab for the Prevention of Menstrually-related Migraine Attacks

Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study

REducing SPEECH-related Side-effects of Deep Brain Stimulation in Parkinson's Disease Via Automated Speech Analysis

Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation

Early Postoperative Day 0 Chest Tube Removal After Thoracoscopic Minor Surgeries

Swiss Revision Cohort

Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis

Epicutaneous Testing of Cosmetics for Skin Compatibility

Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA

Comparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow Reserve and FFRCT